Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726830 · ClinicalTrials.gov registry record · NA
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT00726830: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT00726830 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00726830, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
RATIONALE: Methadone, morphine, or oxycodone may help relieve pain caused by cancer. It is not yet known whether methadone is more effective than morphine or oxycodone in treating pain in patients with cancer. PURPOSE: This randomized clinical trial is studying methadone to see how well it works compared with morphine or oxycodone in treating pain in patients with cancer.
Interventions
- DRUG morphine sulfate
- DRUG oxycodone hydrochloride
- DRUG methadone hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00726830
The ClinicalTrials.gov registry entry for NCT00726830 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which morphine sulfate is the first listed.
NCT00726830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00726830 about?
NCT00726830 is a clinical study titled "Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer". RATIONALE: Methadone, morphine, or oxycodone may help relieve pain caused by cancer. It is not yet known whether methadone is more effective than morphine or oxycodone in treating pain in patients with cancer. PURPOSE: This randomized clinical trial is studying methadone to see how well it works co...
What is the current status of trial NCT00726830?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2009-03. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00726830?
The interventions under investigation include: morphine sulfate (DRUG), oxycodone hydrochloride (DRUG), methadone hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00726830?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.